Authors: Fagot, JP Flahault, A Fodil, M Kanfer, A Alamowitch, S Haymann, JP Lecomte, I Liote, H Parrot, A Rossert, J Verdy, E Becker, A

Citation: Jp. Fagot et al., Impact of expert recommendations on LMWH venous thromboembolism prophylaxis for non-surgery patients on physician prescriptions, PRESSE MED, 30(5), 2001, pp. 203-208

Authors: Fagot, JP Mockenhaupt, M Bouwes-Bavinck, JN Naldi, L Viboud, C Roujeau, JC

Citation: Jp. Fagot et al., Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, AIDS, 15(14), 2001, pp. 1843-1848

Authors: Letrilliart, L Hanslik, T Biour, M Fagot, JP Guiguet, M Flahault, A

Citation: L. Letrilliart et al., Postdischarge adverse drug reactions in primary care originating from hospital care in France - A nationwide prospective study, DRUG SAFETY, 24(10), 2001, pp. 781-792

Authors: Fagot, JP Flahault, A Kanfer, A Benoit, G Bellanger, A Conort, O Durand-Zaleski, I Liote, H Mangin, L Oliary, J Verdy, E Becker, A

Citation: Jp. Fagot et al., Prevention of venous thromboembolism in patients hospitalized for more than 24 hours in a medical ward: proposed indications for low molecular weightheparins, PRESSE MED, 29(1), 2000, pp. 4-10